You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T2DM

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type II, Overweight or Obesity Trial (Shake 1 then Shake 2, Shake 2 then Shake 1)

Not yet recruiting
  • Diabetes Mellitus, Type II
  • Overweight or Obesity
  • Shake 1 then Shake 2
  • Shake 2 then Shake 1
  • (no location specified)
Jul 13, 2023

Nonalcoholic Fatty Liver Disease, Type 2 Diabetes Trial in Damanhur (Dapagliflozin 10mg Tab, Placebo)

Recruiting
  • Nonalcoholic Fatty Liver Disease
  • Type 2 Diabetes
  • Dapagliflozin 10mg Tab
  • Placebo
  • Damanhūr, Elbehairah, Egypt
    Rehab Hussein Werida
Aug 11, 2022

Type 2 Diabetes Mellitus With Cognitive Impairment:Cohort Study

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • whether the participants had T2DM
  • (no location specified)
Feb 6, 2023

Male LADA, T1DM and T2DM Patients

Completed
  • Diabetes
  • No interventions
  • Shanghai, Shanghai, China
    Department of Endocrinology, Shanghai Tenth People's Hospital
Sep 8, 2022

Type 2 Diabetes Trial in Chula Vista (Hepatic Ultrasound Insonification)

Completed
Has Results
  • Type 2 Diabetes
  • Hepatic Ultrasound Insonification
  • Chula Vista, California
    ProSciento
May 9, 2022

T2DM Trial (SHR-3167, SHR-3167 Placebo)

Not yet recruiting
  • T2DM
  • (no location specified)
Aug 16, 2023

Cognitive Functions and BDNF in T2DM and Prediabetes Patients

Completed
  • Diabetes Type 2
  • +2 more
    • Istanbul, Turkey
      Bezmialem Vakif University
    Dec 16, 2022

    Dietary Antioxidants and Thiol Disulfide Homeostasis in T2DM

    Completed
    • Diabetes Mellitus, Type 2
    • Antioxidative Stress
    • Dietary antioxidant intake
    • Ankara, Turkey
      Ankara Yıldırım Beyazıt University
    Jan 16, 2023

    SGLT-2 Inhibitors in T2DM and Moderate to Severe Liver Fibrosis

    Completed
    • Type2diabetes
      • New Delhi, Delhi, India
        Fortis CDOC Hospital
      Jul 14, 2023

      Called SMART-Finder to Look for People With Increased Amounts of

      Not yet recruiting
      • Type 2 Diabetes Mellitus
      • Chronic Kidney Disease
      • Finerenone (Kerendia, BAY94-8862)
      • Type 2 DM drugs
      • Multiple Locations, Germany
        Many locations
      Jan 13, 2023

      Mild Cognitive Impairment, Alzheimer's Disease Trial in Baltimore (grape seed polyphenolic extract, resveratrol)

      Completed
      • Mild Cognitive Impairment
      • Alzheimer's Disease
      • grape seed polyphenolic extract, resveratrol
      • Baltimore, Maryland
        Johns Hopkins University
      Jul 20, 2022

      Type 2 Diabetes (T2DM) Trial in Nanjing (Endovascular denervation System (Generator and Catheter ))

      Recruiting
      • Type 2 Diabetes Mellitus (T2DM)
      • Endovascular denervation System (Generator and Catheter )
      • Nanjing, Jiangsu, China
        Zhongda Hospital, Southeast University
      Jan 2, 2023

      Assessment of Hand Grip Strength Using Jamar Dynamometer

      Recruiting
      • Type2diabetes
      • Using Jamar Dynamometer for Grip Strength.
      • Delhi, India
        Fortis CDOC Hospital
      Jul 10, 2023

      Type 2 Diabetes Trial in Canada, United States (BMF-219)

      Recruiting
      • Type 2 Diabetes Mellitus
      • Montclair, California
      • +5 more
      Feb 22, 2023

      Type2diabetes, Pregnancy Related, Continuous Glucose Monitoring Trial in Beijing (Real-time Continuous Glucose Monitoring

      Recruiting
      • Type2diabetes
      • +4 more
      • Real-time Continuous Glucose Monitoring System
      • Beijing, Beijing, China
        Peking University Third Hospital
      Jul 8, 2023

      Learn More About Chronic Kidney Disease in Type 2 Diabetes

      Completed
      • Type 2 Diabetes Mellitus
      • Chronic Kidney Disease
      • No intervention
      • Multiple Locations, Canada
        Many Locations
      Nov 18, 2022

      PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, T2D Trial in Nantong (control group: lifestyle intervention+ metformin+

      Enrolling by invitation
      • PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
      • T2D
      • control group: lifestyle intervention+ metformin+ orlistat (obese patients)+ pioglitazone
      • the experimental group: lifestyle intervention+ metformin+ orlistat (obese patients)+ Chiglitazar
      • Nantong, Jiangsu, China
        Gu Yunjuan
      Feb 27, 2023

      Beta Cell Dysfunction Trial in Shanghai (overexpression STRA6/miRNA3)

      Completed
      • Beta Cell Dysfunction
      • overexpression STRA6/miRNA3
      • Shanghai, Shanghai, China
        Xiaoyun Cheng
      Oct 8, 2022

      Type 2 Diabetes Trial in Beijing (HSK7653 10 mg, HSK7653 25 mg, HSK7653 50 mg)

      Completed
      • Type 2 Diabetes Mellitus
      • HSK7653 10 mg
      • +3 more
      • Beijing, Beijing, China
        Peking university people's hospital
      Sep 23, 2023

      T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)

      Completed
      • T2DM (Type 2 Diabetes Mellitus)
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Aug 1, 2023

      Diabetes, Type 2, Overweight or Obesity Trial in Ningbo (lifestyle intervention)

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • Overweight or Obesity
      • lifestyle intervention
      • Ningbo, Zhejiang, China
        Ningbo First Hospital
      Sep 27, 2022

      T2DM Trial (Chiglitazar, Empagliflozin, Atorvastatin)

      Not yet recruiting
      • T2DM
      • (no location specified)
      Dec 27, 2022

      T2DM (Type 2 Diabetes) Trial (DWP16001 0.3 mg)

      Not yet recruiting
      • T2DM (Type 2 Diabetes Mellitus)
      • DWP16001 0.3 mg
      • (no location specified)
      Nov 15, 2023

      Liver Fat, Liver Fibrosis, Glycemic Control Trial (Ertugliflozin 5 mg, 15mg)

      Not yet recruiting
      • Liver Fat
      • +5 more
      • Ertugliflozin 5 mg, 15mg
      • (no location specified)
      Nov 30, 2022

      T2DM (Type 2 Diabetes), Hypertension, Heart Disease Chronic Trial (Virtual Group Visit)

      Not yet recruiting
      • T2DM (Type 2 Diabetes Mellitus)
      • +6 more
      • Virtual Group Visit
      • (no location specified)
      Oct 17, 2023